Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis

INTRODUCTION: People treated with haemodialysis are at increased risk for all-cause and cardiovascular mortality. Plasma magnesium concentration has been inversely associated with these risks. Therefore, plasma magnesium may be a new modifiable risk factor and an increase of dialysate magnesium conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Leenders, Nicoline H J, Douma, Caroline E., Hoenderop, Joost G.J., Vervloet, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680141/
https://www.ncbi.nlm.nih.gov/pubmed/36410806
http://dx.doi.org/10.1136/bmjopen-2022-063524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680141/
https://www.ncbi.nlm.nih.gov/pubmed/36410806
http://dx.doi.org/10.1136/bmjopen-2022-063524

Ejemplares similares